Back to Authors

Goche, Flavia

Mayo Clinic

Mayo Clinic

Citations 1

Microglial SWELL1 deficiency drives male-specific seizure vulnerability but paradoxical neuroprotection through impaired phagocytosis
Barath, Abhijeet S. , Dheer, Aastha , Montier, Laura, Peshoff, Mekenzie M, Dale, Emily C., Goche, Flavia, Kleidonas, Dimitrios, Harris, Lauren, Jewanee, Sarah A., Bosco, Dale B. , Haruwaka, Koichiro , Sah, Rajan , Peshoff, Mekenzie , Dale, Emily, Peshoff, Mekenzie M, Goche, Flavia, Nguyen, Thanh Thanh L. , Akter, Mastura , Qi, Fangfang , Kleidonas, Dimitrios, Harris, Lauren, Jewanee, Sarah A., Umpierre, Anthony D. , Wu, Long‐Jun

JCI Insight | June 21, 2026 | Volume: 11 | Issue: 12 | Pages: No page available

10.1172/jci.insight.197980 Get It

The discovery of genes encoding the volume-regulated anion channel (VRAC) has enabled detailed exploration of its cell type–specific roles in the brain. LRRC8A (SWELL1) is the essential VRAC subunit. We observed seizure-induced, subunit-specific changes in microglial VRAC expression and investigated its function using conditional KO (cKO) of LRRC8A in microglia. SWELL1 cKO mice exhibited a male-specific increase in kainate-induced seizure severity, yet showed paradoxical neuroprotection against seizure-associated neuronal loss. Mechanistically, SWELL1 deletion led to a cell-autonomous reduction in microglial density and decreased release of VRAC-permeable neuroactive metabolites, including taurine, GABA, and glutamate in culture. Additionally, impaired phagocytic kinetics and reduced lysosomal biogenesis contributed to the observed neuroprotection. These findings reveal potentially novel roles for microglial VRAC in regulating seizure outcomes and microglia-neuron interactions.